Report for: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia

Title	Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia
Published in	Hematology Transfusion and Cell Therapy, November 2021
DOI	10.1016/j.htct.2021.09.002
Pubmed ID	34794791
Authors	Adriana Seber, Claudio Galvão de CastroJunior, Lucila N. Kerbauy, Alexandre V. Hirayama, Carmem Bonfim, Juliana Folloni Fernandes, Mair Souza, Rony Schafell, Samir Nabhan, Sandra Regina Loggetto, Belinda Pinto Simões, Vanderson Rocha, Marcos de Lima, Renato L. Guerino-Cunha, Henrique Bittencourt

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Canada	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	21	100%

Readers by professional status	Count	As %
Student > Bachelor	4	19%
Unspecified	2	10%
Other	2	10%
Lecturer	1	5%
Student > Ph. D. Student	1	5%
Other	1	5%
Unknown	10	48%

Readers by discipline	Count	As %
Medicine and Dentistry	4	19%
Unspecified	2	10%
Pharmacology, Toxicology and Pharmaceutical Science	2	10%
Nursing and Health Professions	2	10%
Environmental Science	1	5%
Other	0	0%
Unknown	10	48%

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia